Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B

Biochemistry and Cell Biology

Volumn 89, Issue 2, 2011, Pages 138-147

  Dmitriev, Oleg Y ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

ATP7B; Cancer chemotherapy; Cisplatin; Drug resistance; Wilson disease

Indexed keywords

ATP7B; CANCER CHEMOTHERAPY; CIS-PLATIN; DRUG RESISTANCE; WILSON DISEASE;

BINDING SITES; BIOCHEMISTRY; CHEMOTHERAPY; COPPER; DETOXIFICATION; DISEASES; PLATINUM; TUMORS;

PLATINUM COMPOUNDS;

CISPLATIN; PLATINUM; WILSON DISEASE PROTEIN;

AMINO TERMINAL SEQUENCE; BINDING SITE; CATALYSIS; CYTOSOL; DETOXIFICATION; DRUG BINDING; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; IN VIVO STUDY; METAL BINDING; MOLECULAR WEIGHT; PROTEIN DOMAIN; REVIEW; TUMOR RESISTANCE;

ADENOSINE TRIPHOSPHATASES; ANTINEOPLASTIC AGENTS; BINDING SITES; BIOLOGICAL TRANSPORT; CATION TRANSPORT PROTEINS; CISPLATIN; COPPER; DRUG RESISTANCE, NEOPLASM; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEOPLASMS; PLATINUM; PROTEIN BINDING;

EID: 79953752779     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/O10-150     Document Type: Review

References (79)

1. Achila, D., Banci, L., Bertini, I., Bunce, J., Ciofi-Baffoni, S., and Huffman, D.L. 2006. Structure of human Wilson protein domains 5 and 6 and their interplay with domain 4 and the copper chaperone HAH1 in copper uptake. Proc. Natl. Acad. Sci. U.S.A. 103(15): 5729-5734. doi:10.1073/pnas.0504472103. PMID:16571664.
2. Banci, L., Bertini, I., Del Conte, R., D'Onofrio, M., and Rosato, A. 2004. Solution structure and backbone dynamics of the Cu(I) and apo forms of the second metal-binding domain of the Menkes protein ATP7A. Biochemistry, 43(12): 3396-3403. doi:10.1021/bi036042s. PMID:15035611. (Pubitemid 38391696)
3. Banci, L., Bertini, I., Cantini, F., Migliardi, M., Rosato, A., and Wang, S. 2005. An atomic-level investigation of the diseasecausing A629P mutant of the Menkes protein, ATP7A. J. Mol. Biol. 352(2): 409-U7. doi:10.1016/j.jmb.2005. 07.034. PMID:16083905.
4. Banci, L., Bertini, I., Cantini, F., Migliardi, M., Natile, G., Nushi, F., and Rosato, A. 2009. Solution structures of the actuator domain of ATP7A and ATP7B, the Menkes and Wilson disease proteins. Biochemistry, 48(33): 7849-7855. doi:10.1021/bi901003k. PMID:19645496.
5. Banci, L., Bertini, I., Cantini, F., Inagaki, S., Migliardi, M., and Rosato, A. 2010. The binding mode of ATP revealed by the solution structure of the N-domain of human ATP7A. J. Biol. Chem. 285(4): 2537-2544. doi:10.1074/jbc.M109.054262. PMID:19917612.
6. Boal, A.K., and Rosenzweig, A.C. 2009. Crystal structures of cisplatin bound to a human copper chaperone. J. Am. Chem. Soc. 131(40): 14196-14197. doi:10.1021/ja906363t. PMID:19807176.
7. Boulikas, T., and Vougiouka, M. 2003. Cisplatin and platinum drugs at the molecular level. Oncol. Rep. 10(6): 1663-1682. [Review. PMID:14534679.
8. Bull, P.C., Thomas, G.R., Rommens, J.M., Forbes, J.R., and Cox, D.W. 1993. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet. 5(4): 327-337. doi:10.1038/ng1293-327. PMID:8298639. (Pubitemid 23351302)
9. Cater, M.A., Forbes, J., La Fontaine, S., Cox, D., and Mercer, J.F. 2004. Intracellular trafficking of the human Wilson protein: the role of the six N-terminal metal-binding sites. Biochem. J. 380(3): 805-813. doi:10.1042/BJ20031804. PMID:14998371. (Pubitemid 38850522)
10. Culotta V.C., and Gitlin, J. D. 2001. The disorders of copper transport. In The molecular basis of inherited disease, 8th ed (2). Edited by C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle. McGraw-Hill, New York. pp. 3105-3126.
11. Danks, D.M. 1995. Disorders of copper transport. In The metabolic and molecular bases of inherited disease. Edited by C.R. Scriver. McGraw-Hill, Inc., New York, pp. 2211-2235.
12. De Feo, C.J., Aller, S.G., Siluvai, G.S., Blackburn, N.J., and Unger, V.M. 2009. Three-dimensional structure of the human copper transporter hCTR1. Proc. Natl. Acad. Sci. U.S.A. 106(11): 4237-4242. doi:10.1073/pnas.0810286106. PMID:19240214.
13. DiDonato, M., Narindrasorasak, S., Forbes, J.R., Cox, D.W., and Sarkar, B. 1997. Expression, purification, and metal binding properties of the N-terminal domain from the Wilson disease putative copper-transporting ATPase (ATP7B). J. Biol. Chem. 272(52): 33279-33282. doi:10.1074/jbc.272.52.33279. PMID:9407118. (Pubitemid 28023676)
14. Dmitriev, O., Tsivkovskii, R., Abildgaard, F., Morgan, C.T., Markley, J.L., and Lutsenko, S. 2006. Solution structure of the Ndomain of Wilson disease protein: distinct nucleotide-binding environment and effects of disease mutations. Proc. Natl. Acad. Sci. U.S.A. 103(14): 5302-5307. doi:10.1073/pnas.0507416103. PMID:16567646.
15. Dolgova, N.V., Olson, D., Lutsenko, S., and Dmitriev, O.Y. 2009. The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin. Biochem. J. 419(1): 51-56, 3, 56. doi:10.1042/BJ20081359. PMID:19173677.
16. Fan, B., Grass, G., Rensing, C., and Rosen, B.P. 2001. Escherichia coli CopA N-terminal Cys(X)2Cys motifs are not required for copper resistance or transport. Biochem. Biophys. Res. Commun. 286(2): 414-U8. doi:10.1006/bbrc.2001. 5367. PMID:11500054.
17. Forbes, J.R., Hsi, G., and Cox, D.W. 1999. Role of the copper-binding domain in the copper transport function of ATP7B, the P-type ATPase defective in Wilson disease. J. Biol. Chem. 274(18): 12408-12413. doi:10.1074/jbc.274.18. 12408. PMID:10212214.
18. Gitschier, J., Moffat, B., Reilly, D., Wood, W.I., and Fairbrother, W.J. 1998. Solution structure of the fourth metal-binding domain from the Menkes copper-transporting ATPase. Nat. Struct. Biol. 5(1): 47-54. doi:10.1038/nsb0198- 47. PMID:9437429. (Pubitemid 28048976)
19. González-Guerrero, M., and Argüello, J.M. 2008. Mechanism of Cu+-transporting ATPases: soluble Cu+ chaperones directly transfer Cu+ to transmembrane transport sites. Proc. Natl. Acad. Sci. U.S.A. 105(16): 5992-5997. doi:10.1073/pnas.0711446105. PMID:18417453. (Pubitemid 351758387)
20. González-Guerrero, M., Eren, E., Rawat, S., Stemmler, T.L., and Argüello, J.M. 2008. Structure of the two transmembrane Cu+ transport sites of the Cu+-ATPases. J. Biol. Chem. 283(44): 29753-29759. doi:10.1074/jbc. M803248200. PMID:18772137.
21. Holzer, A.K., Samimi, G., Katano, K., Naerdemann, W., Lin, X., Safaei, R., and Howell, S.B. 2004. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells. Mol. Pharmacol. 66(4): 817-823. doi:10.1124/mol.104.001198. PMID:15229296. (Pubitemid 39319453)
22. Howell, S.B., Safaei, R., Larson, C.A., and Sailor, M.J. 2010. Copper transporters and the cellular pharmacology of the platinumcontaining cancer drugs. Mol. Pharmacol. 77(6): 887-894. doi:10.1124/mol.109.063172. PMID:20159940.
23. Huster, D., and Lutsenko, S. 2003. The distinct roles of the Nterminal copper-binding sites in regulation of catalytic activity of the Wilson's disease protein. J. Biol. Chem. 278(34): 32212-32218. doi:10.1074/jbc.M305408200. PMID:12794172. (Pubitemid 37048413)
24. Ishida, S., Lee, J., Thiele, D.J., and Herskowitz, I. 2002. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc. Natl. Acad. Sci. U.S.A. 99(22): 14298-14302. doi:10.1073/pnas. 162491399. PMID:12370430. (Pubitemid 35257666)
25. Ishikawa, T., and Ali-Osman, F. 1993. Glutathione-associated cisdiamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J. Biol. Chem. 268(27): 20116-20125. PMID:8376370. (Pubitemid 23278910)
26. Ivanov, A.I., Christodoulou, J., Parkinson, J.A., Barnham, K.J., Tucker, A., Woodrow, J., and Sadler, P.J. 1998. Cisplatin binding sites on human albumin. J. Biol. Chem. 273(24): 14721-14730. doi:10.1074/jbc.273.24.14721. PMID:9614070. (Pubitemid 28272756)
27. Jamieson, E.R., and Lippard, S.J. 1999. Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev. 99(9): 2467-2498. doi:10.1021/cr980421n. PMID:11749487.
28. Kalayda, G.V., Wagner, C.H., Buß, I., Reedijk, J., and Jaehde, U. 2008. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. BMC Cancer, 8(1): 175. doi:10. 1186/1471-2407-8-175. PMID:18565219.
29. Katano, K., Safaei, R., Samimi, G., Holzer, A., Rochdi, M., and Howell, S.B. 2003. The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. Mol. Pharmacol. 64(2): 466-473. doi:10.1124/mol.64.2. 466. PMID:12869652. (Pubitemid 36910011)
30. Kim, G.P., and Erlichman, C. 2007. Oxaliplatin in the treatment of colorectal cancer. Expert Opin. Drug Metab. Toxicol. 3(2): 281-294. doi:10.1517/17425255.3.2.281. PMID:17428157. (Pubitemid 47316043)
31. Klomp, L.W.J., Lin, S.-J., Yuan, D.S., Klausner, R.D., Culotta, V.C., and Gitlin, J.D. 1997. Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J. Biol. Chem. 272(14): 9221-9226. doi:10.1074/jbc.272.14.9221. PMID:9083055. (Pubitemid 27154931)
32. Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z.S., Terada, K., Furukawa, T., et al. 2000. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 60(5): 1312-1316. PMID:10728692. (Pubitemid 30152000)
33. Kovach, J.S., Moertel, C.G., Schutt, A.J., Reitemeier, R.G., and Hahn, R.G. 1973. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel. Cancer Chemother. Rep. 57(3): 357-359. PMID:4584486.
34. Krieger, M.L., Eckstein, N., Schneider, V., Koch, M., Royer, H.D., Jaehde, U., and Bendas, G. 2010. Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro. Int. J. Pharm. 389(1-2): 10-17. doi:10.1016/j.ijpharm.2009.12.061. PMID:20060458.
35. Kuo, M.T., Chen, H.H., Song, I.S., Savaraj, N., and Ishikawa, T. 2007. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev. 26(1): 71-83. doi:10.1007/s10555-0079045-3. PMID:17318448. (Pubitemid 46452185)
36. Larson, C.A., Blair, B.G., Safaei, R., and Howell, S.B. 2009. The role of the mammalian copper transporter 1 in the cellular accu-mulation of platinum-based drugs. Mol. Pharmacol. 75(2): 324-330. doi:10.1124/mol.108. 052381. PMID:18996970.
37. Larson, C.A., Adams, P.L., Blair, B.G., Safaei, R., and Howell, S. 2010. The role of the methionines and histidines in the transmembrane domain of mammalian Copper Transporter 1 in the cellular accumulation of cisplatin. Mol. Pharmacol. 78(3): 333-339. PMID:20519567.
38. Leonhardt, K., Gebhardt, R., Mossner, J., Lutsenko, S., and Huster, D. 2009. Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug. J. Biol. Chem. 284(12): 7793-7802. doi:10.1074/jbc. M805145200. PMID:19141620.
39. Liang, Z.D., Stockton, D., Savaraj, N., and Tien Kuo, M. 2009. Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin. Mol. Pharmacol. 76(4): 843-853. doi:10.1124/mol.109.056416. PMID:19570948.
40. Lin, X., Okuda, T., Holzer, A., and Howell, S.B. 2002. The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Mol. Pharmacol. 62(5): 1154-1159. doi:10.1124/mol.62.5.1154. PMID:12391279. (Pubitemid 35222507)
41. Lokich, J., Zipoli, T., Greene, R., Paul, S., Sonnenborn, H., and Moore, C. 1986. Protracted low-dose cisplatin infusion in advanced colorectal cancer. Cancer Treat. Rep. 70(4): 523-524. PMID:3698046. (Pubitemid 16116461)
42. Lübben, M., Guldenhaupt, J., Zoltner, M., Deigweiher, K., Haebel, P., Urbanke, C., and Scheidig, A.J. 2007. Sulfate acts as phosphate analog on the monomeric catalytic fragment of the CPxATPase CopB from Sulfolobus solfataricus. J. Mol. Biol. 369(2): 368-385. doi:10.1016/j.jmb.2007.03.029. PMID:17434529. (Pubitemid 46695733)
43. Lutsenko, S., Petrukhin, K., Cooper, M.J., Gilliam, C.T., and Kaplan, J.H. 1997. N-terminal domains of human copper-transporting adenosine triphosphatases (the Wilson's and Menkes disease proteins) bind copper selectively in vivo and in vitro with stoichiometry of one copper per metal-binding repeat. J. Biol. Chem. 272(30): 18939-18944. doi:10.1074/jbc.272. 30.18939. PMID:9228074. (Pubitemid 27318247)
44. Lutsenko, S., Barnes, N.L., Bartee, M.Y., and Dmitriev, O.Y. 2007a. Function and regulation of human copper-transporting ATPases. Physiol. Rev. 87(3): 1011-1046. doi:10.1152/physrev. 00004.2006. PMID:17615395. (Pubitemid 47084675)
45. Lutsenko, S., LeShane, E.S., and Shinde, U. 2007b. Biochemical basis of regulation of human copper-transporting ATPases. Arch. Biochem. Biophys. 463(2): 134-148. doi:10.1016/j.abb. 2007.04.013. PMID:17562324. (Pubitemid 47030341)
46. Mandal, A.K., and Arguello, J.M. 2003. Functional roles of metal binding domains of the Archaeoglobus fulgidus Cu+-ATPase CopA. Biochemistry, 42(37): 11040-11047. doi:10.1021/bi034806y. PMID:12974640. (Pubitemid 37174396)
47. Mandic, A., Hansson, J., Linder, S., and Shoshan, M.C. 2003. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J. Biol. Chem. 278(11): 9100-9106. doi:10.1074/jbc.M210284200. PMID:12509415. (Pubitemid 36800390)
48. Mangala, L.S., Zuzel, V., Schmandt, R., Leshane, E.S., Halder, J.B., Armaiz-Pena, G.N., et al. 2009. Therapeutic targeting of ATP7B in ovarian carcinoma. Clin. Cancer Res. 15(11): 3770-3780. doi:10.1158/1078-0432.CCR-08- 2306. PMID:19470734.
49. McKeage, M.J. 2005. New-generation platinum drugs in the treatment of cisplatin-resistant cancers. Expert Opin. Investig. Drugs, 14(8): 1033-1046. doi:10.1517/13543784.14.8.1033. PMID:16050795. (Pubitemid 41131654)
50. Miller, S.E., and House, D.A. 1990. The hydrolysis products of cisdichlorodiammineplatinum(II). 3. Hydrolysis kinetics at physiological pH. Inorg. Chim. Acta, 173(1): 53-60. doi:10.1016/ S0020-1693(00)91054-5.
51. Muller, P.A., and Klomp, L.W. 2009. ATOX1: a novel copperresponsive transcription factor in mammals? Int. J. Biochem. Cell Biol. 41(6): 1233-1236. doi:10.1016/j.biocel.2008.08.001. PMID:18761103.
52. Nakagawa, T., Inoue, Y., Kodama, H., Yamazaki, H., Kawai, K., Suemizu, H., et al. 2008. Expression of copper-transporting Ptype adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts. Oncol. Rep. 20(2): 265-270. PMID:18636185.
53. Nakayama, K., Kanzaki, A., Ogawa, K., Miyazaki, K., Neamati, N., and Takebayashi, Y. 2002. Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int. J. Cancer, 101(5): 488-495. doi:10.1002/ijc.10608. PMID:12216079.
54. Nakayama, K., Kanzaki, A., Terada, K., Mutoh, M., Ogawa, K., Sugiyama, T., et al. 2004. Prognostic value of the Cutransporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy. Clin. Cancer Res. 10(8): 2804-2811. doi:10.1158/1078-0432.CCR-03-0454. PMID:15102688. (Pubitemid 38509159)
55. Pattanaik, A., Bachowski, G., Laib, J., Lemkuil, D., Shaw, C.F., 3rd, Petering, D.H., et al. 1992. Properties of the reaction of cis- dichlorodiammineplatinum(II) with metallothionein. J. Biol. Chem. 267(23): 16121-16128. PMID:1644799.
56. Petrukhin, K., Fischer, S.G., Pirastu, M., Tanzi, R.E., Chernov, I., Devoto, M., et al. 1993. Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat. Genet. 5(4): 338-343. doi:10.1038/ng1293-338. PMID:8298640. (Pubitemid 23351303)
57. Prast-Nielsen, S., Cebula, M., Pader, I., and Arner, E.S. 2010. Noble metal targeting of thioredoxin reductase - covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin. Free Radic. Biol. Med. 49(11):1765-1778. PMID:20851179.
58. Roche, P.A., Jensen, P.E., and Pizzo, S.V. 1988. Intersubunit crosslinking by cis-dichlorodiammineplatinum(II) stabilizes an a2macroglobulin "nascent" state: evidence that thiol ester bond cleavage correlates with receptor recognition site exposure. Biochemistry, 27(2): 759-764. doi:10.1021/bi00402a040. PMID:2450578. (Pubitemid 18043518)
59. Rosenberg, B., Vancamp, L., and Krigas, T. 1965. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature, 205(4972): 698-699. doi:10.1038/205698a0. PMID:14287410.
60. Rosenberg, B., Van Camp, L., Grimley, E.B., and Thomson, A.J. 1967. The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum(IV) complexes. J. Biol. Chem. 242(6): 1347-1352. PMID:5337590.
61. Safaei, R., Katano, K., Samimi, G., Naerdemann, W., Stevenson, J.L., Rochdi, M., and Howell, S.B. 2004. Cross-resistance to cisplatin in cells with acquired resistance to copper. Cancer Chemother. Pharmacol. 53(3): 239-246. doi:10.1007/s00280-003-0736-3. PMID:14648017. (Pubitemid 38293722)
62. Safaei, R., Otani, S., Larson, B.J., Rasmussen, M.L., and Howell, S.B. 2008. Transport of cisplatin by the copper efflux transporter ATP7B. Mol. Pharmacol. 73(2): 461-468. doi:10.1124/mol.107. 040980. PMID:17978167. (Pubitemid 351159216)
63. Safaei, R., Maktabi, M.H., Blair, B.G., Larson, C.A., and Howell, S.B. 2009. Effects of the loss of Atox1 on the cellular pharmacology of cisplatin. J. Inorg. Biochem. 103(3): 333-341. doi:10.1016/j.jinorgbio.2008.11.012. PMID:19124158.
64. Samimi, G., Varki, N.M., Wilczynski, S., Safaei, R., Alberts, D.S., and Howell, S.B. 2003. Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clin. Cancer Res. 9(16 Pt 1): 5853-5859. PMID:14676106. (Pubitemid 38018067)
65. Samimi, G., Safaei, R., Katano, K., Holzer, A.K., Rochdi, M., Tomioka, M., et al. 2004. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin. Cancer Res. 10(14): 4661-4669. doi:10.1158/1078-0432.CCR-04-0137. PMID:15269138. (Pubitemid 38955516)
66. Sazinsky, M.H., Mandal, A.K., Arguello, J.M., and Rosenzweig, A.C. 2006. Structure of the ATP binding domain from the Archaeoglobus fulgidus Cu+-ATPase. J. Biol. Chem. 281(16): 11161-11166. doi:10.1074/jbc.M510708200. PMID:16495228. (Pubitemid 43855541)
67. Siddik, Z.H. 2003. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene, 22(47): 7265-7279. doi:10. 1038/sj.onc.1206933. PMID:14576837. (Pubitemid 37487159)
68. Song, I.S., Savaraj, N., Siddik, Z.H., Liu, P., Wei, Y., Wu, C.J., and Kuo, M.T. 2004. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatinsensitive and cisplatin-resistant cells. Mol. Cancer Ther. 3(12): 1543-1549. PMID:15634647. (Pubitemid 40136709)
69. Stewart, D.J. 2007. Mechanisms of resistance to cisplatin and car-boplatin. Crit. Rev. Oncol. Hematol. 63(1): 12-31. doi:10.1016/ j.critrevonc.2007.02.001. PMID:17336087.
70. Tanzi, R.E., Petrukhin, K., Chernov, I., Pellequer, J.L., Wasco, W., Ross, B., et al. 1993. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat. Genet. 5(4): 344-350. doi:10.1038/ng1293-344. PMID:8298641. (Pubitemid 23351304)
71. Tsivkovskii, R., Eisses, J.F., Kaplan, J.H., and Lutsenko, S. 2002. Functional properties of the copper-transporting ATPase ATP7B (the Wilson's disease protein) expressed in insect cells. J. Biol. Chem. 277(2): 976-983. doi:10.1074/jbc.M109368200. PMID:11677246. (Pubitemid 34968842)
72. Tsuda, T., and Toyoshima, C. 2009. Nucleotide recognition by CopA, a Cu+-transporting P-type ATPase. EMBO J. 28(12): 1782-1791. doi:10.1038/emboj. 2009.143. PMID:19478797.
73. Vulpe, C., Levinson, B., Whitney, S., Packman, S., and Gitschier, J. 1993. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet. 3(1): 7-13. doi:10.1038/ng0193-7. PMID:8490659. (Pubitemid 23063281)
74. Wang, D., and Lippard, S.J. 2005. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 4(4): 307-320. doi:10.1038/nrd1691. PMID:15789122. (Pubitemid 41130944)
75. Wells, W.W., Rocque, P.A., Xu, D.P., Yang, Y., and Deits, T.L. 1991. Interactions of platinum complexes with thioltransferase(glutaredoxin), in vitro. Biochem. Biophys. Res. Commun. 180(2): 735-741. doi:10.1016/S0006- 291X(05)81127-1. PMID:1953747.
76. Wernimont, A.K., Huffman, D.L., Lamb, A.L., O'Halloran, T.V., and Rosenzweig, A.C. 2000. Structural basis for copper transfer by the metallochaperone for the Menkes/Wilson disease proteins. Nat. Struct. Biol. 7(9): 766-771. doi:10.1038/78999. PMID:10966647.
77. Yatsunyk, L.A., and Rosenzweig, A.C. 2007. Cu(I) binding and transfer by the N terminus of the Wilson disease protein. J. Biol. Chem. 282(12): 8622-8631. doi:10.1074/jbc.M609533200. PMID:17229731. (Pubitemid 47093492)
78. Yoshizawa, K., Nozaki, S., Kitahara, H., Ohara, T., Kato, K., Kawashiri, S., and Yamamoto, E. 2007. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines. Oncol. Rep. 18(4): 987-991. PMID:17786364.
79. Zisowsky, J., Koegel, S., Leyers, S., Devarakonda, K., Kassack, M.U., Osmak, M., and Jaehde, U. 2007. Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells. Biochem. Pharmacol. 73(2): 298-307. doi:10.1016/j.bcp.2006.10.003. PMID:17097621. (Pubitemid 44855730)